Citation Tools

Download PDFPDF

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

Download to a citation manager

Cite this article as:
Curti B, Daniels GA, McDermott DF, et al
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry